diabetes-falkensee.de - Centre for Clinical Studies Dr. Luedemann
- Address
- Poststrasse 46, 14612 Falkensee, Germany
Centre for Clinical Studies Dr. Luedemann - Cardiovascular Disease Research
The Centre for Clinical Studies Dr. Luedemann in Falkensee specializes in advanced cardiovascular research, with particular expertise in atherosclerotic cardiovascular disease (ASCVD) and lipid management. The center conducts Phase 3 clinical trials focused on evaluating novel therapeutic interventions for patients with established cardiovascular disease who require optimized treatment strategies beyond conventional lipid-modifying therapies.
- Atherosclerotic cardiovascular disease and plaque buildup management
- Advanced lipid-modifying therapies and CETP inhibition studies
- Major adverse cardiovascular events (MACE) prevention research
- Coronary revascularization and secondary prevention strategies
The research center plays a crucial role in investigating innovative approaches to reduce the risk of major adverse cardiovascular events, including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and non-elective coronary revascularization. By participating in international multi-center trials, Dr. Luedemann's facility contributes to the development of next-generation treatments for patients with atherosclerotic heart and blood vessel disease, particularly those whose current lipid management remains suboptimal despite existing therapeutic interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Kailera Therapeutics Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Kailera Therapeutics Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in diabetes-falkensee.de - Centre for Clinical Studies Dr. Luedemann
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of AZD9550 and AZD6234 Co-administration in Obesity or Overweight Patients with Comorbidities: A Phase IIb Randomized Study | AstraZeneca AB | Phase II | Not Recruiting | Feb 2025 | May 2026 |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HRS 9531 | 2 | Unknown | 2026-06-16 | 2026-06-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.